"Stomach Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the STOMACH.
Descriptor ID |
D013274
|
MeSH Number(s) |
C04.588.274.476.767 C06.301.371.767 C06.405.249.767 C06.405.748.789
|
Concept/Terms |
Stomach Neoplasms- Stomach Neoplasms
- Neoplasm, Stomach
- Stomach Neoplasm
- Neoplasms, Stomach
- Gastric Neoplasms
- Gastric Neoplasm
- Neoplasm, Gastric
- Neoplasms, Gastric
Cancer of Stomach- Cancer of Stomach
- Stomach Cancers
- Gastric Cancer
- Cancer, Gastric
- Cancers, Gastric
- Gastric Cancers
- Stomach Cancer
- Cancer, Stomach
- Cancers, Stomach
- Cancer of the Stomach
|
Below are MeSH descriptors whose meaning is more general than "Stomach Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Stomach Neoplasms".
This graph shows the total number of publications written about "Stomach Neoplasms" by people in this website by year, and whether "Stomach Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 4 | 0 | 4 |
1996 | 1 | 1 | 2 |
1997 | 10 | 2 | 12 |
1998 | 2 | 6 | 8 |
1999 | 11 | 3 | 14 |
2000 | 7 | 3 | 10 |
2001 | 5 | 0 | 5 |
2002 | 9 | 2 | 11 |
2003 | 3 | 3 | 6 |
2004 | 4 | 5 | 9 |
2005 | 6 | 6 | 12 |
2006 | 10 | 5 | 15 |
2007 | 8 | 3 | 11 |
2008 | 8 | 5 | 13 |
2009 | 15 | 6 | 21 |
2010 | 12 | 1 | 13 |
2011 | 9 | 2 | 11 |
2012 | 8 | 2 | 10 |
2013 | 10 | 5 | 15 |
2014 | 13 | 6 | 19 |
2015 | 8 | 4 | 12 |
2016 | 11 | 1 | 12 |
2017 | 11 | 3 | 14 |
2018 | 20 | 2 | 22 |
2019 | 19 | 1 | 20 |
2020 | 25 | 2 | 27 |
2021 | 11 | 3 | 14 |
2022 | 15 | 0 | 15 |
2023 | 22 | 0 | 22 |
2024 | 11 | 5 | 16 |
2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Stomach Neoplasms" by people in Profiles.
-
Helicobacter pylori virulence factor CagA promotes Snail-mediated epithelial-mesenchymal transition and invasive behavior by downregulating Semaphorin 5A in gastric epithelial cells. Biochem Biophys Res Commun. 2025 Mar 01; 750:151421.
-
Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study. ESMO Open. 2025 Feb; 10(2):104107.
-
Primary gastric T-cell lymphoma presenting with perforation: a case report and review of the literature. J Hematop. 2024 Dec 30; 18(1):2.
-
The Landscape of Helicobacter pylori-related Gastric Carcinogenesis. J Gastrointestin Liver Dis. 2024 Dec 28; 33(4):524-534.
-
Circulating Chromogranin A as a Surveillance Biomarker in Patients with Carcinoids-The CASPAR Study. Clin Cancer Res. 2024 Dec 16; 30(24):5559-5567.
-
Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete Response. JCO Precis Oncol. 2024 Dec; 8:e2400288.
-
HSP90 inhibitor AUY922 suppresses tumor growth and modulates immune response through YAP1-TEAD pathway inhibition in gastric cancer. Cancer Lett. 2025 Feb 01; 610:217354.
-
HIPEC for metastatic gastric cancer: Moving the needle towards 3-year survival. Eur J Surg Oncol. 2025 Jan; 51(1):108790.
-
Targeted Dynamic Phospho-Proteogenomic Analysis of Gastric Cancer Cells Suggests Host Immunity Provides Survival Benefit. Mol Cell Proteomics. 2024 Dec; 23(12):100870.
-
DKN-01 in Combination With Tislelizumab and Chemotherapy as First-Line Therapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: DisTinGuish. J Clin Oncol. 2025 Jan 20; 43(3):339-349.